CytomX Therapeutics's market cap is currently $554.11M. The company's EPS TTM is $0; its P/E ratio is 5.88; CytomX Therapeutics is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
